methamphetamine has been researched along with Dyskinesia, Drug-Induced in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (25.00) | 18.7374 |
1990's | 2 (16.67) | 18.2507 |
2000's | 2 (16.67) | 29.6817 |
2010's | 5 (41.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Rusyniak, DE | 2 |
Cong, B; Gou, H; Li, M; Li, Y; Liu, L; Ma, C; Wen, D; Zhang, W | 1 |
Grill, WM; McConnell, GC; So, RQ | 1 |
Breger, LS; Dunnett, SB; Lane, EL; Smith, GA | 1 |
Ito, Y; Mizoguchi, H; Nabeshima, T; Nagai, T; Nitta, A; Niwa, M; Noda, Y | 1 |
Inada, T; Oda, T; Yamamoto, N | 1 |
Gospe, SM | 1 |
Ando, K | 1 |
Carlson, KR | 1 |
Carlson, KR; Eibergen, RD | 2 |
3 review(s) available for methamphetamine and Dyskinesia, Drug-Induced
Article | Year |
---|---|
Neurologic manifestations of chronic methamphetamine abuse.
Topics: Amphetamine-Related Disorders; Cognition Disorders; Dental Caries; Dyskinesia, Drug-Induced; Humans; Methamphetamine; Paresthesia; Parkinson Disease, Secondary; Psychoses, Substance-Induced; Stereotyped Behavior | 2013 |
Neurologic manifestations of chronic methamphetamine abuse.
Topics: Amphetamine-Related Disorders; Central Nervous System Stimulants; Dyskinesia, Drug-Induced; Humans; Methamphetamine; Paresthesia; Parkinsonian Disorders | 2011 |
Test methods for predicting tardive toxicity of therapeutic drugs using laboratory animals.
Topics: Animals; Antipsychotic Agents; Cebus; Central Nervous System Stimulants; Dyskinesia, Drug-Induced; Learning Disabilities; Methamphetamine; Rats; Toxicity Tests | 1996 |
9 other study(ies) available for methamphetamine and Dyskinesia, Drug-Induced
Article | Year |
---|---|
Protective effects of cholecystokinin-8 on methamphetamine-induced behavioral changes and dopaminergic neurodegeneration in mice.
Topics: Amphetamine-Related Disorders; Animals; Body Temperature; Cholecystokinin; Corpus Striatum; Dopamine Agents; Dopamine Plasma Membrane Transport Proteins; Dopaminergic Neurons; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Male; Methamphetamine; Mice, Inbred C57BL; Motor Activity; Neurodegenerative Diseases; Neuroprotective Agents; Peptide Fragments; Random Allocation; Stereotyped Behavior; Substantia Nigra; Tyrosine 3-Monooxygenase | 2015 |
Failure to suppress low-frequency neuronal oscillatory activity underlies the reduced effectiveness of random patterns of deep brain stimulation.
Topics: Action Potentials; Animals; Central Nervous System Stimulants; Deep Brain Stimulation; Dopamine D2 Receptor Antagonists; Dyskinesia, Drug-Induced; Female; Globus Pallidus; Haloperidol; Implantable Neurostimulators; Methamphetamine; Microelectrodes; Neural Inhibition; Neurons; Oxidopamine; Parkinsonian Disorders; Pars Reticulata; Rats, Long-Evans; Subthalamic Nucleus | 2016 |
Pharmacological modulation of amphetamine-induced dyskinesia in transplanted hemi-parkinsonian rats.
Topics: Animals; Anti-Dyskinesia Agents; Cell Transplantation; Disease Models, Animal; Dopamine Antagonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Dyskinesias; Excitatory Amino Acid Antagonists; Female; Mesencephalon; Methamphetamine; Neostriatum; Nerve Tissue Proteins; Neurons; Parkinson Disease; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, Neurotransmitter; Serotonin Receptor Agonists | 2012 |
A novel molecule "shati" is involved in methamphetamine-induced hyperlocomotion, sensitization, and conditioned place preference.
Topics: Acetyltransferases; Amino Acid Sequence; Animals; Behavior, Animal; Brain; Conditioning, Psychological; Dopamine; Dyskinesia, Drug-Induced; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Molecular Sequence Data; RNA, Messenger; Tissue Distribution | 2007 |
Methamphetamine psychosis in which tardive dystonia was successfully treated with clonazepam.
Topics: Aged; Anti-Dyskinesia Agents; Antipsychotic Agents; Benzodiazepines; Biperiden; Central Nervous System Stimulants; Clonazepam; Dyskinesia, Drug-Induced; Hallucinations; Haloperidol; Humans; Male; Methamphetamine; Olanzapine; Posture; Psychoses, Substance-Induced; Risperidone | 2007 |
Transient cortical blindness in an infant exposed to methamphetamine.
Topics: Acute Disease; Akathisia, Drug-Induced; Blindness; Cerebral Cortex; Diagnosis, Differential; Dyskinesia, Drug-Induced; Humans; Infant; Male; Methamphetamine; Neurologic Examination | 1995 |
A syndrome resembling tardive dyskinesia which results from chronic methadone treatment.
Topics: Animals; Dyskinesia, Drug-Induced; Guinea Pigs; Haplorhini; Methadone; Methamphetamine | 1978 |
Dyskinesias in monkeys: interaction of methamphetamine with prior methadone treatment.
Topics: Animals; Chlorpromazine; Clozapine; Diazepam; Dyskinesia, Drug-Induced; Haloperidol; Haplorhini; Humans; Macaca mulatta; Male; Methadone; Methamphetamine; Naloxone; Phenobarbital; Phentolamine; Physostigmine; Spiperone; Stereotyped Behavior | 1976 |
Susceptibility to amphetamine-elicited dyskinesias following chronic methadone treatment in monkeys.
Topics: Animals; Chlorpromazine; Clozapine; Diazepam; Drug Interactions; Dyskinesia, Drug-Induced; Haloperidol; Haplorhini; Macaca mulatta; Male; Methadone; Methamphetamine; Phenobarbital; Phentolamine; Physostigmine; Spiperone; Time Factors | 1976 |